0001209191-23-001313.txt : 20230104 0001209191-23-001313.hdr.sgml : 20230104 20230104181246 ACCESSION NUMBER: 0001209191-23-001313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rowland Charles A Jr CENTRAL INDEX KEY: 0001383292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 23508708 MAIL ADDRESS: STREET 1: 3338 LANCASHIRE RD CITY: FURLONG STATE: PA ZIP: 18925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 0 0001607678 Viking Therapeutics, Inc. VKTX 0001383292 Rowland Charles A Jr C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 8.52 2023-01-03 4 A 0 22000 0.00 A 2024-01-03 2033-01-03 Common Stock 22000 22000 D /s/ Michael Morneau, as Attorney-in-Fact 2023-01-04